MODULATORS OF BRCA1 ACTIVITY

(19)

(11)

EP 0 929 668 A1

(12)

(43)	Date of publication:
	21.07.1999 Bulletin 1999/29

(21)	Application number: 97935333.0

(22)	Date of filing: 06.08.1997

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61P 43/ 00^{( . )}
C07K 14/ 47^{( . )}
C12N 1/ 15^{( . )}
C12N 1/ 21^{( . )}
C12N 15/ 12^{( . )}
C12P 21/ 08^{( . )}

A61K 38/ 00^{( . )}
C07K 14/ 435^{( . )}
C07K 16/ 18^{( . )}
C12N 1/ 19^{( . )}
C12N 5/ 10^{( . )}
C12P 21/ 02^{( . )}

(86)	International application number:
	PCT/US1997/013944

(87)	International publication number:
	WO 1998/010066 (12.03.1998 Gazette 1998/10)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

04.09.1996 US 19960025601P

(71)	Applicant: ONYX PHARMACEUTICALS, INC.
	Richmond, CA 94806 (US)

(72)	Inventors:
	RUBINFELD, Bonnee Danville, CA 94526 (US) POLAKIS, Paul Mill Valley, CA 94941 (US) LIGENFELTER, Carol Oakland, CA 94610 (US) VUONG, Terilyn, T. Oakland, CA 94602 (US)

(74)	Representative: Cripps, Joanna Elizabeth, et al
	Mewburn Ellis York House 23 Kingsway GB-London WC2B 6HP GB-London WC2B 6HP (GB)

(54)	MODULATORS OF BRCA1 ACTIVITY